Skip to content
EHS Insiders

Case Studies

Real engagements. Anonymized for NDA.

Three representative projects from the past few years. Client names are withheld; the work and outcomes are not.

Series A, first dedicated lab spaceSouth San Francisco, CA

Stand-up of a full EHS program for a 45-person preclinical biotech

Anonymized — 45-person preclinical biotech

Read full case study

Challenge

The company had signed a lease on a 12,000 sq ft shared lab facility and had 60 days before move-in. No existing EHS programs, no HMBP, no EPA ID, no chemical hygiene plan — and a landlord requiring proof of compliance before key turnover.

Approach

  • Built the full chemical inventory and HMBP submittal in coordination with local CUPA.
  • Drafted Chemical Hygiene Plan, BBP program, HazCom, and emergency action plan aligned to site hazards.
  • Stood up waste streams and obtained EPA ID via RCRAInfo/eVQ.
  • Delivered initial new-hire EHS training to the full team, tracked in a shared roster.

Outcome

  • Cleared landlord compliance review on schedule; keys released on time.
  • Passed first CUPA inspection with zero violations and one administrative correction.
  • Handed over a maintenance runbook the internal ops lead could operate month-to-month.
Post Series B, 3 sites across 2 statesBay Area + Boston

Multi-site EHS harmonization for a diagnostics company across 3 labs

Anonymized — growth-stage diagnostics company

Read full case study

Challenge

Three sites had grown independently, each with its own version of the same programs — plus a pending acquisition about to add a fourth. Training records were fragmented across folders, inspectors had started asking harder questions, and leadership needed one consistent story.

Approach

  • Audited all three sites and produced a gap analysis mapped to OSHA, EPA, and DOT requirements.
  • Rebuilt a single set of master EHS programs with site-specific appendices.
  • Consolidated training records into a single roster with automated renewal tracking.
  • Ran in-person refresh training at each site during rollout.

Outcome

  • Reduced duplicate policy documents by ~70% while expanding coverage.
  • Passed two back-to-back regulatory inspections post-rollout with no findings.
  • Produced a repeatable integration playbook used to onboard the acquired 4th site in under 30 days.
Series B, active BSL-2 research operationsSan Francisco Bay Area, CA

Post-leak mold investigation and remediation oversight for a BSL-2 research facility

Anonymized — private biotech R&D company, single-tenant building

Read full case study

Challenge

A chilled water line leak above a BSL-2 lab ceiling went undetected over a weekend. By Monday, two employees had reported respiratory symptoms and visible water staining had spread across multiple ceiling tiles. The employer had an IIPP obligation to investigate reported hazards — but no protocol for mold assessment, no remediation contractor on file, and active research that couldn't be shut down indefinitely.

Approach

  • Phase 1 — visual and moisture survey: pin/pinless moisture mapping of ACT, drywall, and subfloor; IR thermography of suspect wall cavities; HVAC supply/return inspection to assess cross-contamination risk.
  • Phase 2 — air sampling: spore trap (Air-O-Cell) samples at six indoor locations plus one outdoor control, collected before remediation began to establish baseline and scope.
  • Phase 3 — surface sampling: tape lifts on suspect ceiling tiles and bulk sampling of removed ACT to identify genera and inform remediation approach.
  • Wrote the remediation scope of work for the abatement contractor: containment boundaries, negative pressure requirements, PPE, and disposal procedures per IICRC S520.
  • Provided on-site oversight during remediation and conducted post-remediation verification (PRV) air sampling to confirm clearance before the lab reopened.

Outcome

  • Lab cleared for full reoccupancy 11 days after initial assessment, with zero PRV exceedances.
  • Employee symptom reports resolved; documentation package provided to HR and occupational health for recordkeeping.
  • Identified a secondary moisture intrusion point in the HVAC return plenum that the original leak response had missed — remediated before it became a second event.
Commercial, multi-shift warehouse operationLos Angeles, CA

EtO exposure determination for an overlooked worker population at a medical device company

Anonymized — commercial-stage medical device company

Read full case study

Challenge

The company had a mature EtO sterilization compliance program covering their contract sterilizer — but their own warehouse and shipping/receiving staff, who handled incoming sterilized pallets three times a week, had never been included. No exposure determination, no monitoring, no training, no medical surveillance. An EHS review flagged the gap six weeks before a scheduled Cal/OSHA inspection.

Approach

  • Defined four Similar Exposure Groups across receiving, forklift, QC inspection, and pick/pack operations — none of whom were in the existing EtO compliance program.
  • Conducted personal full-shift TWA sampling (OSHA Method 50) and 15-minute STEL samples during pallet arrival and stretch-wrap removal across two sampling days.
  • Deployed continuous EtO monitoring at dock, staging zone, and quarantine room throughout each shift to map concentration peaks and decay.
  • Built an off-gas decay curve for typical incoming loads to establish a minimum safe quarantine hold time before manual handling.
  • Extended the existing EtO compliance program to all warehouse SEGs: regulated area designation, training, medical surveillance enrollment, and a periodic monitoring schedule per §5220(d)(4).

Outcome

  • Cal/OSHA inspection resulted in zero EtO-related citations.
  • Established a repeatable incoming-load monitoring protocol the safety team could operate independently.
  • Identified two receiving employees who had been handling freshly-arrived pallets for three-plus years with no monitoring — both enrolled in medical surveillance per §5220 requirements.
Phase II, preparing for a regulator visitBerkeley, CA

Hazardous waste turnaround for a small-molecule pharma developer

Anonymized — clinical-stage small-molecule pharma

Read full case study

Challenge

A routine internal review surfaced multiple hazwaste issues — mislabeled accumulation containers, undocumented satellite accumulation areas, and a 90-day container about to go over. A regulator visit was on the calendar for the following month.

Approach

  • Completed an emergency waste stream re-profiling across the facility.
  • Re-labeled and consolidated all accumulation areas; documented every SAA.
  • Coordinated a compliant disposal event with the site's hazwaste vendor.
  • Rewrote the site's waste SOPs and trained all generators before the visit.

Outcome

  • Full hazwaste compliance restored within 3 weeks.
  • Regulator visit resulted in zero waste-related findings.
  • Site transitioned to a recurring monthly EHS support engagement.

Got a situation that looks like one of these?

Send us the short version. We'll tell you whether we can help.

Request consultation